{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:42:32Z","timestamp":1788280952712,"version":"build-2803163510"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T00:00:00Z","timestamp":1364256000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059674","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T16:48:23Z","timestamp":1364316503000},"page":"e59674","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of In Vitro Cross-Reactivity to Avian H5N1 and Pandemic H1N1 2009 Influenza Following Prime Boost Regimens of Seasonal Influenza Vaccination in Healthy Human Subjects: A Randomised Trial"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct01044095","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Delia","family":"Bethell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Jongkaewwattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarin","family":"Kramyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunee","family":"Thitithayanont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwimon","family":"Wiboon-ut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosol","family":"Yongvanitchit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amporn","family":"Limsalakpetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utaiwan","family":"Kum-Arb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichapat","family":"Uthaimongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ans E.","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke","family":"Engering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duangrat","family":"Mongkolsirichaikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuanpan","family":"Khemnu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Tyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathit","family":"Pichyangkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (2013) Cumulative number of confirmed human cases of avian influenza a(H5N1) reported to WHO. Geneva.Accessed 25 February 2013. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/index.html\" xlink:type=\"simple\">http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/index.html<\/ext-link>"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"RJ Cox","year":"2004","journal-title":"Scand J Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"NJ Carter","year":"2011","journal-title":"Drugs"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/j.spid.2006.08.007","article-title":"Live attenuated influenza vaccine in children","volume":"17","author":"CS Ambrose","year":"2006","journal-title":"Semin Pediatr Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1128\/JVI.74.21.10025-10033.2000","article-title":"A human immunodeficiency virus prime-boost immunization regimen in humans induces antibodies that show interclade cross-reactivity and neutralize several X4-, R5-, and dualtropic clade B and C primary isolates","volume":"74","author":"F Verrier","year":"2000","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"SJ McConkey","year":"2003","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1099\/vir.0.83018-0","article-title":"Virus distribution of the attenuated MVA and NYVAC poxvirus strains in mice","volume":"88","author":"CE Gomez","year":"2007","journal-title":"J Gen Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.1192517","article-title":"Induction of broadly neutralizing H1N1 influenza antibodies by vaccination","volume":"329","author":"CJ Wei","year":"2010","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcv.2009.10.009","article-title":"Optimization and evaluation of an influenza A (H5) pseudotyped lentiviral particle-based serological assay","volume":"47","author":"JM Garcia","year":"2010","journal-title":"J Clin Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses","volume":"107","author":"AG Grandea","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0022-1759(90)90255-T","article-title":"Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates","volume":"135","author":"CR Lambre","year":"1990","journal-title":"J Immunol Methods"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1073\/pnas.82.6.1785","article-title":"Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes","volume":"82","author":"JW Yewdell","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/sim.4780141709","article-title":"On the use of a pilot sample for sample size determination","volume":"14","author":"RH Browne","year":"1995","journal-title":"Stat Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j..2002.384.doc.x","article-title":"Design and analysis of pilot studies: recommendations for good practice","volume":"10","author":"GA Lancaster","year":"2004","journal-title":"J Eval Clin Pract"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1086\/428948","article-title":"Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a potential priming strategy","volume":"191","author":"BR Stephenson I","year":"2005","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","article-title":"Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial","volume":"368","author":"JZJ Lin","year":"2006","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","article-title":"Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza","volume":"357","author":"CA Nicholson KG","year":"2001","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"KF Schulz","year":"2010","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3201\/eid1401.061283","article-title":"Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza","volume":"14","author":"C Gioia","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e8805","DOI":"10.1371\/journal.pone.0008805","article-title":"Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals","volume":"5","author":"D Corti","year":"2010","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"J Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ni.2067","article-title":"Systems biology of vaccination for seasonal influenza in humans","volume":"12","author":"HI Nakaya","year":"2011","journal-title":"Nat Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1073\/pnas.1115369109","article-title":"Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection","volume":"109","author":"T Onodera","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"BR Murphy","year":"1972","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","article-title":"Effect of neuraminidase antibody on Hong Kong influenza","volume":"1","author":"AS Monto","year":"1973","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/507309","article-title":"Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children","volume":"194","author":"JL Neuzil KM","year":"2006","journal-title":"J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"20365","DOI":"10.1073\/pnas.0911580106","article-title":"Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population","volume":"106","author":"JA Greenbaum","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","first-page":"3478","article-title":"Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals","volume":"118","author":"LY Lee","year":"2008","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1128\/JVI.02226-09","article-title":"Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus","volume":"84","author":"X Ge","year":"2010","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-3083.1978.tb00428.x","article-title":"Cytotoxic T cells in the lungs of mice infected with an influenza A virus","volume":"7","author":"KL Yap","year":"1978","journal-title":"Scand J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/eji.1830100515","article-title":"Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice","volume":"10","author":"RG Webster","year":"1980","journal-title":"Eur J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.01812-10","article-title":"T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model","volume":"85","author":"H Guo","year":"2011","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"TM Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1016\/j.vaccine.2009.03.088","article-title":"Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members","volume":"27","author":"AA Eick","year":"2009","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jama.2009.265","article-title":"Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel","volume":"301","author":"Z Wang","year":"2009","journal-title":"JAMA"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:23:38Z","timestamp":1539995018000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059674"}},"subtitle":[],"editor":[{"given":"Toru","family":"Takimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059674","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}